» Articles » PMID: 35203561

A Novel Role of Galectin-3 and Thyroglobulin in Prognosis and Differentiation of Different Stages of Thyroid Cancer and Elucidation of the Potential Contribution of Bcl-2, IL-8 and TNF-α

Overview
Journal Biomedicines
Date 2022 Feb 25
PMID 35203561
Authors
Affiliations
Soon will be listed here.
Abstract

Thyroid cancer is among the most prevalent cancers with different types and stages. New markers are required for the prognosis and diagnosis of the disease. The present study aimed to detect the role of new markers, including galectin-3 (Gal-3) and thyroglobulin (TG), in the prognosis and staging of thyroid cancer. The study also investigated the potential apoptotic and inflammatory mechanisms involved in thyroid cancer through the determination of B-cell lymphoma 2 (Bcl-2), interleukin-8 (IL-8) and tumor necrosis factor α (TNFα) during the different stages of the cancer using a series of molecular methods. Histopathological and immunohistochemical examinations were also performed. A total of 300 subjects were classified into: 100 normal healthy subjects matched in age and sex, 100 patients with thyroid carcinoma stage I (T1N0M0) and 100 patients with thyroid carcinoma stage 2 (T2N1M1). Interestingly, the present study revealed a significant increase in the levels of TG and Gal-3 in thyroid cancer patients compared to the control group. Furthermore, the levels of Bcl-2, IL-8 and TNF-α significantly increased in the patient serum. The histopathological examination and immunohistochemical observations confirmed the molecular and hematological findings. Collectively, the present study concluded that serum TG and Gal-3 could be useful markers in the prognosis and staging of patients with thyroid cancer. Furthermore, the determination of Bax, Bcl-2, IL-8 and TNF-α levels constitute a major important marker for investigation of the mechanisms of apoptosis and inflammation in thyroid cancer. To our knowledge, this is the first study that used both galectin-3 and TG as tumor markers in the prognosis and differentiation between the different stages of cancer.

Citing Articles

Design and Optimization of Sesamol Nanosuspensions to Potentiate the Anti-Tumor Activity of Epirubicin against Ehrlich Solid Carcinoma-Bearing Mice.

Elzanaty K, Omran G, Elmahallawy E, Albrakati A, Saleh A, Dahran N Pharmaceutics. 2024; 16(7).

PMID: 39065634 PMC: 11279961. DOI: 10.3390/pharmaceutics16070937.


Correlation analysis of serum thyroglobulin, thyroid-stimulating hormone levels, and thyroid-cancer risk in thyroid nodule surgery.

Shuai J, Leng Z, Wang P, Ji Y World J Clin Cases. 2023; 11(27):6407-6414.

PMID: 37900235 PMC: 10600984. DOI: 10.12998/wjcc.v11.i27.6407.


Promotion of IL‑17/NF‑κB signaling in autoimmune thyroid diseases.

Lu Y, Xing C, Zhang C, Lv X, Liu G, Chen F Exp Ther Med. 2023; 25(1):51.

PMID: 36588813 PMC: 9780515. DOI: 10.3892/etm.2022.11750.


Galectin-3 in prostate cancer and heart diseases: a biomarker for these two frightening pathologies?.

Lima T, Perpetuo L, Henrique R, Fardilha M, Leite-Moreira A, Bastos J Mol Biol Rep. 2022; 50(3):2763-2778.

PMID: 36583779 PMC: 10011345. DOI: 10.1007/s11033-022-08207-1.

References
1.
Hamivand Z, Haddadi G, Fardid R . Expression of Bax and Bcl2 Genes in Peripheral Blood Lymphocytes of Patients with Differentiated Thyroid Cancer. J Med Phys. 2018; 43(1):41-45. PMC: 5879822. DOI: 10.4103/jmp.JMP_104_17. View

2.
Bauerle K, Schweppe R, Lund G, Kotnis G, Deep G, Agarwal R . Nuclear factor κB-dependent regulation of angiogenesis, and metastasis in an in vivo model of thyroid cancer is associated with secreted interleukin-8. J Clin Endocrinol Metab. 2014; 99(8):E1436-44. PMC: 4121024. DOI: 10.1210/jc.2013-3636. View

3.
Makki F, Taylor S, Shahnavaz A, Leslie A, Gallant J, Douglas S . Serum biomarkers of papillary thyroid cancer. J Otolaryngol Head Neck Surg. 2013; 42:16. PMC: 3651213. DOI: 10.1186/1916-0216-42-16. View

4.
Xing M . Molecular pathogenesis and mechanisms of thyroid cancer. Nat Rev Cancer. 2013; 13(3):184-99. PMC: 3791171. DOI: 10.1038/nrc3431. View

5.
Okda T, Abd-Elghaffar S, Katary M, Abd-Alhaseeb M . Chemopreventive and anticancer activities of indomethacin and vitamin D combination on colorectal cancer induced by 1,2-dimethylhydrazine in rats. Biomed Rep. 2021; 14(2):27. PMC: 7780749. DOI: 10.3892/br.2020.1403. View